Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027
SKU ID : QYR-18743174 | Publishing Date : 14-Jul-2021 | No. of pages : 133
Detailed TOC of Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027
1 Study Coverage1.1 Tick-borne Encephalitis Inactivated Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Type
1.2.2 European TBE Virus
1.2.3 Far Eastern TBE Virus
1.2.4 Siberian TBE Virus
1.3 Market by Application
1.3.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Application
1.3.2 Pediatric Vaccines
1.3.3 Adult Vaccines
1.3.4 Traveler Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Revenue 2016-2027
2.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Sales 2016-2027
2.2 Global Tick-borne Encephalitis Inactivated Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Tick-borne Encephalitis Inactivated Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Tick-borne Encephalitis Inactivated Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Tick-borne Encephalitis Inactivated Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Tick-borne Encephalitis Inactivated Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Region (2022-2027)
3 Global Tick-borne Encephalitis Inactivated Vaccine Competitor Landscape by Players
3.1 Global Top Tick-borne Encephalitis Inactivated Vaccine Manufacturers by Sales
3.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Tick-borne Encephalitis Inactivated Vaccine Manufacturers by Revenue
3.2.1 Key Tick-borne Encephalitis Inactivated Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Tick-borne Encephalitis Inactivated Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Tick-borne Encephalitis Inactivated Vaccine Revenue in 2020
3.2.6 Global Tick-borne Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tick-borne Encephalitis Inactivated Vaccine Price by Manufacturers
3.4 Global Tick-borne Encephalitis Inactivated Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Tick-borne Encephalitis Inactivated Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tick-borne Encephalitis Inactivated Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Tick-borne Encephalitis Inactivated Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size by Type (2016-2021)
4.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021)
4.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type (2016-2021)
4.1.3 Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Tick-borne Encephalitis Inactivated Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size by Application (2016-2021)
5.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021)
5.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application (2016-2021)
5.1.3 Tick-borne Encephalitis Inactivated Vaccine Price by Application (2016-2021)
5.2 Tick-borne Encephalitis Inactivated Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Tick-borne Encephalitis Inactivated Vaccine Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
6.1.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales YoY Growth 2016-2027
6.1.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue YoY Growth 2016-2027
6.1.3 United States Tick-borne Encephalitis Inactivated Vaccine Market Share in Global Market 2016-2027
6.2 United States Tick-borne Encephalitis Inactivated Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Tick-borne Encephalitis Inactivated Vaccine Players by Sales (2016-2021)
6.2.2 United States Top Tick-borne Encephalitis Inactivated Vaccine Players by Revenue (2016-2021)
6.3 United States Tick-borne Encephalitis Inactivated Vaccine Historic Market Review by Type (2016-2021)
6.3.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2021)
6.3.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 United States Tick-borne Encephalitis Inactivated Vaccine Price by Type (2016-2021)
6.4 United States Tick-borne Encephalitis Inactivated Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Type (2022-2027)
6.4.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 United States Tick-borne Encephalitis Inactivated Vaccine Price Forecast by Type (2022-2027)
6.5 United States Tick-borne Encephalitis Inactivated Vaccine Historic Market Review by Application (2016-2021)
6.5.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2021)
6.5.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 United States Tick-borne Encephalitis Inactivated Vaccine Price by Application (2016-2021)
6.6 United States Tick-borne Encephalitis Inactivated Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Application (2022-2027)
6.6.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 United States Tick-borne Encephalitis Inactivated Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
7.2 North America Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
7.2.1 North America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
7.2.2 North America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
9.2.1 Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
9.2.2 Europe Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
10.2.1 Latin America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.1.5 Pfizer Recent Development
12.2 Encephalitis
12.2.1 Encephalitis Corporation Information
12.2.2 Encephalitis Description and Business Overview
12.2.3 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.2.5 Encephalitis Recent Development
12.3 Cochrane Collaboration
12.3.1 Cochrane Collaboration Corporation Information
12.3.2 Cochrane Collaboration Description and Business Overview
12.3.3 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.3.5 Cochrane Collaboration Recent Development
12.4 Sonic HealthPlus
12.4.1 Sonic HealthPlus Corporation Information
12.4.2 Sonic HealthPlus Description and Business Overview
12.4.3 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.4.5 Sonic HealthPlus Recent Development
12.5 Superdrug Health
12.5.1 Superdrug Health Corporation Information
12.5.2 Superdrug Health Description and Business Overview
12.5.3 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.5.5 Superdrug Health Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Tick-borne Encephalitis Inactivated Vaccine Industry Trends
13.2 Tick-borne Encephalitis Inactivated Vaccine Market Drivers
13.3 Tick-borne Encephalitis Inactivated Vaccine Market Challenges
13.4 Tick-borne Encephalitis Inactivated Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tick-borne Encephalitis Inactivated Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027
List of TablesTable 1. Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of European TBE Virus
Table 3. Major Manufacturers of Far Eastern TBE Virus
Table 4. Major Manufacturers of Siberian TBE Virus
Table 5. Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Tick-borne Encephalitis Inactivated Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Regions (2016-2021) & (K Units)
Table 8. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Tick-borne Encephalitis Inactivated Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Tick-borne Encephalitis Inactivated Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Tick-borne Encephalitis Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Tick-borne Encephalitis Inactivated Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tick-borne Encephalitis Inactivated Vaccine as of 2020)
Table 21. Key Manufacturers Tick-borne Encephalitis Inactivated Vaccine Price (2016-2021) (USD/Unit)
Table 22. Tick-borne Encephalitis Inactivated Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Tick-borne Encephalitis Inactivated Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Tick-borne Encephalitis Inactivated Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021) (K Units)
Table 27. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Type (2016-2021)
Table 28. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Type (2016-2021)
Table 30. Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021) (K Units)
Table 37. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Application (2016-2021)
Table 38. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Application (2016-2021)
Table 40. Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 47. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Company (2016-2021)
Table 48. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Company (2016-2021)
Table 50. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Type (2016-2021)
Table 51. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Type (2016-2021)
Table 52. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Type (2016-2021)
Table 54. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Type (2022-2027)
Table 55. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Type (2022-2027)
Table 56. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Type (2022-2027)
Table 58. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Type (2022-2027)
Table 59. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Application (2016-2021)
Table 60. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Application (2016-2021)
Table 61. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Application (2016-2021)
Table 63. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Application (2022-2027)
Table 64. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Application (2022-2027)
Table 65. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Application (2022-2027)
Table 67. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Application (2022-2027)
Table 68. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
Table 69. North America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
Table 77. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Pfizer Corporation Information
Table 89. Pfizer Description and Business Overview
Table 90. Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Pfizer Tick-borne Encephalitis Inactivated Vaccine Product
Table 92. Pfizer Recent Development
Table 93. Encephalitis Corporation Information
Table 94. Encephalitis Description and Business Overview
Table 95. Encephalitis Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Encephalitis Product
Table 97. Encephalitis Recent Development
Table 98. Cochrane Collaboration Corporation Information
Table 99. Cochrane Collaboration Description and Business Overview
Table 100. Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Cochrane Collaboration Product
Table 102. Cochrane Collaboration Recent Development
Table 103. Sonic HealthPlus Corporation Information
Table 104. Sonic HealthPlus Description and Business Overview
Table 105. Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Sonic HealthPlus Product
Table 107. Sonic HealthPlus Recent Development
Table 108. Superdrug Health Corporation Information
Table 109. Superdrug Health Description and Business Overview
Table 110. Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Superdrug Health Product
Table 112. Superdrug Health Recent Development
Table 113. Tick-borne Encephalitis Inactivated Vaccine Market Trends
Table 114. Tick-borne Encephalitis Inactivated Vaccine Market Drivers
Table 115. Tick-borne Encephalitis Inactivated Vaccine Market Challenges
Table 116. Tick-borne Encephalitis Inactivated Vaccine Market Restraints
Table 117. Tick-borne Encephalitis Inactivated Vaccine Customers List
Table 118. Tick-borne Encephalitis Inactivated Vaccine Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Tick-borne Encephalitis Inactivated Vaccine Product Picture
Figure 2. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. European TBE Virus Product Picture
Figure 4. Far Eastern TBE Virus Product Picture
Figure 5. Siberian TBE Virus Product Picture
Figure 6. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application in 2020 & 2027
Figure 7. Pediatric Vaccines
Figure 8. Adult Vaccines
Figure 9. Traveler Vaccines
Figure 10. Tick-borne Encephalitis Inactivated Vaccine Report Years Considered
Figure 11. Global Tick-borne Encephalitis Inactivated Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Tick-borne Encephalitis Inactivated Vaccine Market Size 2016-2027 (US$ Million)
Figure 13. Global Tick-borne Encephalitis Inactivated Vaccine Sales 2016-2027 (K Units)
Figure 14. Global Tick-borne Encephalitis Inactivated Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region (2016-2021)
Figure 16. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region in 2020
Figure 17. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region (2016-2021)
Figure 18. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region in 2020
Figure 19. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Tick-borne Encephalitis Inactivated Vaccine Revenue in 2020
Figure 21. Tick-borne Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2021)
Figure 23. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type in 2020
Figure 24. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Type (2016-2021)
Figure 25. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Type in 2020
Figure 26. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2021)
Figure 27. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application in 2020
Figure 28. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Application (2016-2021)
Figure 29. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Application in 2020
Figure 30. United States Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2027 (K Units)
Figure 31. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. United States Tick-borne Encephalitis Inactivated Vaccine Market Share in Global Market 2016-2027
Figure 33. United States 5 and 10 Largest Tick-borne Encephalitis Inactivated Vaccine Players Market Share by Revenue in Tick-borne Encephalitis Inactivated Vaccine in 2020
Figure 34. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Type (2016-2021)
Figure 35. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 36. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Application (2016-2021)
Figure 37. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
Figure 41. North America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
Figure 42. U.S. Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
Figure 49. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
Figure 50. Germany Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region in 2020
Figure 63. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region in 2020
Figure 64. China Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 75. Taiwan Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 83. Philippines Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 85. Vietnam Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 87. Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
Figure 89. Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
Figure 90. Mexico Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 91. Mexico Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 93. Brazil Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 95. Argentina Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
Figure 100. Turkey Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 105. UAE Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Tick-borne Encephalitis Inactivated Vaccine Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
Keyplayers in Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027
PfizerEncephalitis
Cochrane Collaboration
Sonic HealthPlus
Superdrug Health